대웅
15,160KRWMarket close of 10/21 (Wed)
Down -2.88%-450KRWMarket close of 10/21 (Wed)
- Open
- 15,560
- High
- 15,670
- Low
- 15,100
- Day range
- Day range low 15,100 high 15,670, open 15,560, close 15,160, previous close 15,610
- Volume
- 5×10K shares
- 746.53 million KRW 0.74× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
1%1-year close range 15,070 to 29,350 won, 1% up from the low
1% of the way up from the lowest close in 1 year (252 sessions) · -48.3% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-2.88%-2.88%, 1.8× the usual (20-session average ±1.64%)That day -2.88% · usual ±1.64% · large-move threshold ±3.3%
The other 3 are within the usual range
- Trading value0.7×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue492.7B KRW
- vs. year ago
- +2.3%
- vs. prior quarter
- -4.6%
- Operating income47.8B KRW
- vs. year ago
- -21.8%
- vs. prior quarter
- +37.4%
- Operating margin9.7%
- vs. year ago
- -3.0 pp
- vs. prior quarter
- +3.0 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.